Last month we were delighted that several our NHS Clinical Entrepreneurs were given the opportunity to pitch to senior leaders at the Medical Advisory Group meeting at Havas Lynx in London.
The Medical Advisory Group made up of national clinical directors, national speciality advisors and regional medical directors, advises the National Medical Director at NHS England on the strategy for improving the quality of care provided by the NHS.
The NHS Clinical Entrepreneurs Programme (CEP), is a workforce development programme open to all NHS staff and delivered by Anglia Ruskin University, The programmes aim is to foster innovation, to allow creative thinkers and entrepreneurs to pursue their ideas without leaving the NHS.. To date, the NHS CEP has supported over 800 healthcare staff to develop and scale their ideas and projects, with 248 staff having either returned or remained within the NHS as a result of the programme.
As part of the wider NHS CEP Pitstop event on the 13th July, several entrepreneurs were given an audience at the Medical Advisory Group meeting with senior leaders that included; Amanda Pritchard, Professor Sir Christopher Whitty, Dr Aidan Fowler, Dr Roger Banks, Celia Ingham-Clark, Professor Tony Young.
Each of the nine entrepreneurs were given 3 minutes to pitch their innovations to the senior clinical leadership of NHS England, followed by an engaging and interactive Q&A session. The innovations covered in the pitches ranged from drone technology, through to addressing health inequalities, AI, health tech, treatment pathways and telemedicine.
These included pitches from:
- Christopher Law and Hammad Jeilani – Apian
- Ben Deldar – Deep Medical
- Rachael Grimaldi – CardMedic
- Tom Harte – MyRecovery
- Stephanie Campbell – OKKO Health
- Malone Mukwende – Hutano
- Bernadette Porter – Neuroresponse
- Nick de Pennington – Ufonia
- Chris Whittle – e Consult
Speaking about the event, Professor Tony Young, National Clinical Lead for Innovation NHS England; Professor of Entrepreneurship And Medical Innovation, Anglia Ruskin University said:
“It is vital to the NHS that we embrace innovation to help transform patient care. The NHS Clinical Entrepreneur Programme helps to support those individuals who can identify the problems currently facing the NHS, and want to be part of the solution.
We were thrilled to have been given the opportunity to invite some of our entrepreneurs along to showcase their innovation to senior leaders. This is just one example of the many opportunities the programme provides.”
‘I was thrilled to attend the MAG event in London – it was such a great opportunity to present to NHSE Leaders with other clinical innovators and to share the NeuroResponse story.’ Said Bernadette Porter a NHS Clinical Entrepreneur, Honorary Consultant Nurse and Founder and CEO of NeuroResponse
The NHS Clinical Entrepreneur Programme is part of the Accelerated Access Collaborative (AAC) which brings together industry, government, regulators, patients and the NHS to remove barriers and accelerate the introduction of new ground-breaking treatments and diagnostics which have the potential to transform care.